[1]
Aal, M.K.A., Nassar, M.B., Elgendy, E. and Badr, S.F. 2021. Evaluation of Time in Therapeutic Range of Patients with Non-Valvular Atrial Fibrillation on Oral Anticoagulation with Vitamin K Antagonist in Delta Region. Cardiology and Angiology: An International Journal. 10, 3 (Jun. 2021), 32-38. DOI:https://doi.org/10.9734/ca/2021/v10i330172.